Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K6NS
|
||||
| Former ID |
DPR000114
|
||||
| Drug Name |
T-226293
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Obesity [ICD9: 278; ICD10:E66] | Preclinical | [1] | ||
| Company |
Schering Plough
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C27H32ClNO2
|
||||
| Canonical SMILES |
CCN(CC)CCOC1=CC=C(C=C1)C(CC2=CC=C(C=C2)Cl)(C3=CC=C(C=C3<br />)C)O
|
||||
| InChI |
1S/C27H32ClNO2/c1-4-29(5-2)18-19-31-26-16-12-24(13-17-26)27(30,23-10-6-21(3)7-11-23)20-22-8-14-25(28)15-9-22/h6-17,30H,4-5,18-20H2,1-3H3
|
||||
| InChIKey |
SYHDSBBKRLVLFF-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
110740, 6687838, 8154186, 16858634, 24724632, 29217665, 29225504, 49967656, 50111719, 52442310, 57323521, 103458476, 103852307, 104057017, 104312340, 117431694, 117463216, 127316187, 127316188, 127316189, 127316190, 127316191, 127316192, 127316193, 127316194, 127316195, 127316196, 127316197, 129306152, 134223593, 134339551, 134340651, 134970758, 137007264, 144205821, 162248430, 163138523, 164765975, 170466640, 179315863, 184536620, 184547379, 226501669, 249950729, 252323520
|
||||
| Target and Pathway | |||||
| Target(s) | Melanin-concentrating hormone receptor 1 | Target Info | Antagonist | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Reactome | Peptide ligand-binding receptors | ||||
| G alpha (q) signalling events | |||||
| G alpha (i) signalling events | |||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.